German Companies Splurge on U.S. Deals

The video tutorial discusses the mergers and acquisitions (M&A) function on the Bloomberg Terminal, focusing on recent acquisitions by German companies in the US. It highlights significant deals by Merck, Zemans, and SAP, noting a trend of German firms investing in the US as a strategy to escape the Eurozone crisis and capitalize on the US economic recovery. The video contrasts these acquisitions with the US inversion deals, where American companies buy European firms to reduce tax liabilities. The tutorial concludes by emphasizing the strategic moves of German companies in the US market.

Which companies were highlighted as major German acquirers in the US this month?

• Merck, Zemans, and SAP

• Pfizer, Bayer, and Siemens

• BASF, Bosch, and Allianz

• Volkswagen, BMW, and Audi

What is one reason German firms are increasing acquisitions in the US?

• To reduce their workforce

• To diversify into the African market

• To increase their presence in Asia

• To escape the eurozone crisis

How much have German firms announced in US deals this year compared to last year?

• $30 billion, five times more

• $10 billion, twice as much

• $100 billion, twenty times more

• $65 billion, almost 18 times more

What is the primary goal of US companies engaging in inversion deals?

• To lower their tax obligations

• To diversify their product lines

• To expand into the Asian market

• To increase their workforce

Which trend do the German acquisitions differ from?

• US inversion deals

• Asian market expansions

• European market consolidations

• Middle Eastern partnerships